[1]晏建国,罗 萍,胡 飞,等.多发性骨髓瘤患者EB病毒检测及其临床意义[J].医学信息,2021,34(15):86-88.[doi:10.3969/j.issn.1006-1959.2021.15.022]
　YAN Jian-guo,LUO Ping,HU Fei,et al.Detection of Epstein-Barr Virus in Patients with Multiple Myeloma and Its Clinical Significance[J].Medical Information,2021,34(15):86-88.[doi:10.3969/j.issn.1006-1959.2021.15.022]
点击复制

多发性骨髓瘤患者EB病毒检测及其临床意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年15期
页码:
86-88
栏目:
论著
出版日期:
2021-08-01

文章信息/Info

Title:
Detection of Epstein-Barr Virus in Patients with Multiple Myeloma and Its Clinical Significance
文章编号:
1006-1959（2021）15-0086-03
作者:
晏建国; 罗 萍; 胡 飞; 等
（九江市第一人民医院血液内科，江西 九江 332000）
Author(s):
YAN Jian-guo; LUO Ping; HU Fei; et al.
(Department of Hematology,First People’s Hospital of Jiujiang City, Jiujiang 332000,Jiangxi,China)
关键词:
EB病毒; EBV-DNA; 多发性骨髓瘤
Keywords:
Epstein-Barr virus; EBV-DNA; Multiple myeloma
分类号:
R733
DOI:
10.3969/j.issn.1006-1959.2021.15.022
文献标志码:
A
摘要:
目的 检测多发性骨髓瘤（MM）患者中EB病毒（EBV）感染情况，探讨其与MM的发生、发展及预后的关系。方法 选取2012年5月~2020年2月在我院住院110例MM患者作为MM组，并选取同期健康者110名作为正常对照组，采用荧光定量PCR检测所有研究对象外周血细胞中EBV-DNA，比较两组EBV感染率及不同分型、不同分期（ISS分期）、不同危险度分层（mSMART）患者外周血细胞中EBV-DNA水平。结果 MM组的EBV感染率为68.18%，高于对照组的8.18%（P＜0.00）；不同分型中EBV-DNA阳性表达率分别为IgG型57.78%、IgA型73.81%、IgD型66.67%、κ轻链型71.14%、入轻链型85.71%、不分泌型100.00%；不同分期（ISS分期）中EBV-DNA阳性表达率分别为Ⅰ期27.78%、Ⅱ期59.09%和Ⅲ期81.43%，且Ⅰ期EBV-DNA阳性表达率高于正常对照组，低于Ⅱ期和Ⅲ期（P＜0.05），Ⅱ期EBV-DNA阳性表达率低于Ⅲ期（P＜0.05）；在不同危险度分层（mSMART）中EBV-DNA阳性表达率分别为低危组（43.75%）、中危组（69.77%）和高危组（88.57%），且低危组EBV-DNA阳性表达率高于正常对照组，低于中危组和高危组（P＜0.05），中危组EBV-DNA阳性表达率低于高危组（P＜0.05）。结论 EBV感染与多发性骨髓瘤的发生可能密切相关，外周血EBV-DNA表达在多发性骨髓瘤患者临床分型、分期、危险度分层的存在差异，通过检测外周血EBV-DNA可作为临床上评估多发性骨髓瘤预后的重要参考指标，有一定的临床参考价值。
Abstract:
Objective To detect Epstein-Barr virus (EBV) infection in patients with multiple myeloma (MM), and to explore its relationship with the occurrence, development and prognosis of MM.Methods A total of 110 patients with MM who were hospitalized in our hospital from May 2012 to February 2020 were selected as the MM group, and 110 healthy people during the same period were selected as the control group.Fluorescence quantitative PCR was used to detect EBV-DNA in peripheral blood cells of all subjects,the EBV infection rate and EBV-DNA levels in peripheral blood cells of patients with different types, different stages (ISS stages) and different risk stratification (mSMART) were compared between the two groups.Results The EBV infection rate in the MM group was 68.18%, which was higher than 8.18% in the control group (P＜0.05);The positive expression rates of EBV-DNA in different types were 57.78% for IgG type, 73.81% for IgA type, 66.67% for IgD type, 71.14% for k light chain type, 85.71% for light chain type, and 100.00% for non-secreted type.The positive expression rates of EBV-DNA in different stages (ISS stages) were 27.78% in stage Ⅰ, 59.09% in stage Ⅱ and 81.43% in stage Ⅲ, respectively and the positive expression rate of EBV-DNA in stage Ⅰ was higher than that in the normal control group, and lower than in stages Ⅱ and Ⅲ (P＜0.05).The positive expression rate of EBV-DNA in stage Ⅱ was lower than that in stage Ⅲ (P＜0.05);The positive expression rates of EBV-DNA in different risk stratification (mSMART) were low-risk group (43.75%), intermediate-risk group (69.77%), and high-risk group (88.57%) and the positive expression rate of EBV-DNA in the low-risk group was higher than that of the normal control group, and lower than the middle-risk group and the high-risk group (P＜0.05).The positive expression rate of EBV-DNA in the intermediate-risk group was lower than that in the high-risk group (P＜0.05).Conclusion EBV infection may be closely related to the occurrence of multiple myeloma. The expression of EBV-DNA in peripheral blood has differences in the clinical classification, staging and risk stratification of patients with multiple myeloma.The detection of EBV-DNA in peripheral blood can be used as an important reference index for clinical evaluation of the prognosis of multiple myeloma, and has certain clinical reference value.

参考文献/References:

[1]Guillerey C,Nakamura K,Vuckovic S,et al.Immune responses in multiple myeloma:role of the natural immune surveillance and potential of immunotherapies[J].Cellular and Molecular Life Sciences CMLS,2016,73(8):1569-1589. [2]刘芳,宋善俊.EB病毒感染与淋巴瘤[J].临床内科杂志,2019,36(6):368-370. [3]Ali AS,Al-Shraim M,Al-Hakami AM,et al.Epstein- Barr Virus:Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis[J].Open Virol J,2014,9(1):7-28. [4]Sawada A,Croom-Carter D,Kondo O,et al.Epstein-Barr virus latent gene sequences as geographical markers of viral origin:unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family[J].The Journal of General Virology,2011,92(Pt 5):1032-1043. [5]Tracy SI,Habermann TM,Feldman AL,et al.Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression[J].Haematologica,2018,103(2):297-303. [6]Lara J,Cohen M,Matteo ED,et al.Epstein-Barr virus(EBV)association and latency profile in pediatric Burkitt’s lymphoma:experience of a single institution in Argentina[J].Journal of Medical Virology,2014,86(5):845-850. [7]Ohashi A,Kato S,Okamoto A,et al.Reappraisal of Epstein-Barr virus(EBV)in diffuse large B-cell lymphoma(DLBCL):comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells[J].Histopathology,2017,71(1):89-97. [8]张之南,沈悌.血液病诊断及疗效标准[M].第3版.北京:科学出版社,2007:315-398. [9]Rasmus S,Klausen TW,Morten S,et al.Immunoparesis in newly diagnosed Multiple Myeloma patients:Effects on overall survival and progression free survival in the Danish population[J].PLoS One,2017,12(12):e0188988. [10]Smirnova OV,Manchuk VT,Agilova YN.[Clinical and Immunological Features of Infectious Complications in Patients with Multiple Myeloma][J].Vestnik Rossiiskoi Akademii Meditsinskikh Nauk,2015,70(5):534. [11]王琦侠,李建英,宋艳萍,等.多发性骨髓瘤与HBV、HCV及EBV病毒感染的关系[J].现代肿瘤医学,2016,24(12):1970-1972. [12]刘娜,王京华,孙志扬,等.血液病患者EB病毒检测的临床意义[J].中华内科杂志,2004,43(8):623-624. [13]桂瑞瑞,祖璎玲,张萸莉,等.供者淋巴细胞鞘内注射治疗异基因造血干细胞移植后EB病毒相关中枢神经系统疾病三例报告并文献复习[J].中华血液学杂志,2019(4):333-335. [14]贺荟静.EB病毒对胃癌中Caveolin-1表达的调控作用和机制研究[D].青岛大学,2019. [15]Kanakry JA,Hegde AM,Durand CM,et al.The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases[J].Blood,2016,127(16):2007. [16]Welch J,Schwartz C L,Higman M,et al.Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma[J].Blood Advances,2017,1(11):681. [17]Katerina V,Maha I,Eszter N,et al.Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma[J].Cancers,2018,10(9):285. [18]Xia B,Wang X,Yang R,et al.Epstein-Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma[J].Bioscience reports,2019,39(10):BSR20190284.

相似文献/References:

[1]高振亮,于 水,彭 冲,等.青岛地区住院患儿EB病毒感染状况分析[J].医学信息,2018,31(18):98.[doi:10.3969/j.issn.1006-1959.2018.18.030]
　GAO Zhen-liang,YU Shui,PENG Chong,et al.Analysis of Epstein-barr Virus Infection Status in Hospitalized Children in Qingdao Area[J].Medical Information,2018,31(15):98.[doi:10.3969/j.issn.1006-1959.2018.18.030]
[2]王兆辉,罗荣华,王绪栋,等.泰安市中心医院儿童大叶肺炎病原学特点及临床分析[J].医学信息,2018,31(22):133.[doi:10.3969/j.issn.1006-1959.2018.22.038]
　WANG Zhao-hui,LUO Rong-hua,WANG Xu-dong,et al.Pathogenic and Clinical Analysis of Children's Lobar Pneumonia in Central Hospital of Tai'an City[J].Medical Information,2018,31(15):133.[doi:10.3969/j.issn.1006-1959.2018.22.038]
[3]王小鹏,王美怡,刘 芬.EB病毒相关性传染性单核细胞增多症患儿并发肝功能异常的高危因素分析[J].医学信息,2022,35(14):66.[doi:10.3969/j.issn.1006-1959.2022.14.014]
　WANG Xiao-peng,WANG Mei-yi,LIU Fen.Analysis of Risk Factors for Liver Dysfunction in Children with EB Virus Infectious Mononucleosis[J].Medical Information,2022,35(15):66.[doi:10.3969/j.issn.1006-1959.2022.14.014]
[4]郑凌云.儿童传染性单核细胞增多症临床特点[J].医学信息,2020,33(02):118.[doi:10.3969/j.issn.1006-1959.2020.02.034]
　ZHENG Ling-yun.Clinical Characteristics of Childhood Infectious Mononucleosis[J].Medical Information,2020,33(15):118.[doi:10.3969/j.issn.1006-1959.2020.02.034]
[5]刘 敏,叶春晖.EB病毒与慢性阻塞性肺疾病的关系及其防治研究[J].医学信息,2020,33(04):32.[doi:10.3969/j.issn.1006-1959.2020.04.011]
　LIU Min,YE Chun-hui.Study on the Relationship between Epstein-Barr Virus and Chronic Obstructive Pulmonary Disease and its prevention[J].Medical Information,2020,33(15):32.[doi:10.3969/j.issn.1006-1959.2020.04.011]

更新日期/Last Update: 1900-01-01